The Requirements for Laboratories Reporting Tests for the National Cervical Screening Program (Second Edition 2019)

This is a publication of the National Pathology Accreditation Advisory Council (NPAAC) which is managed by the Australian Government Department of Health

Page last updated: 26 September 2019

The Requirements for Laboratories Reporting Tests for the National Cervical Screening Program (Second Edition 2019) set out the minimum requirements for best practice for the use of Human Papillomavirus nucleic acid testing as the primary screening method for cervical screening with reflect liquid based cytology in cases of positive oncogenic HPV types.

Testing of self-collected specimens of symptomatic women and in the post-treatment setting has also been considered.

This document will come into effect the day after the legislative amendment is registered in the Federal Register of Legislation.

PDF version: Requirements for Laboratories Reporting Tests for the National Cervical Screening Program (Second Edition 2019) (PDF 574 KB)
Word version: Requirements for Laboratories Reporting Tests for the National Cervical Screening Program (Second Edition 2019) (Word 116 KB)

Should you have any further queries please contact the NPAAC Secretariat.

In this section